Shilpa Medicare Ltd Hits Intraday High with 7.95% Surge on 1 Feb 2026

Intraday Trading Highlights

On the trading day, Shilpa Medicare Ltd demonstrated significant momentum, touching an intraday peak of Rs 313.5, which represents an 8.1% rise from its previous close. The stock exhibited elevated volatility, with an intraday volatility measure of 17.93% calculated from the weighted average price, indicating active price swings throughout the session. This volatility was accompanied by a strong upward trajectory, as the stock outperformed its sector peers by 7.1% during the day.

The stock has been on a positive streak, registering gains for two consecutive days and delivering a cumulative return of 15.8% over this period. This recent performance contrasts with its longer-term trends, where the stock has experienced mixed returns relative to the broader market benchmarks.

Technical Positioning and Moving Averages

From a technical perspective, Shilpa Medicare Ltd’s current price stands above its 5-day and 20-day moving averages, signalling short-term strength. However, it remains below the 50-day, 100-day, and 200-day moving averages, suggesting that medium to long-term momentum has yet to fully align with the recent gains. This positioning highlights a potential transitional phase in the stock’s price action, with short-term bullishness amid longer-term consolidation.

Comparative Market Context

While Shilpa Medicare Ltd surged intraday, the broader market displayed a contrasting trend. The Sensex opened 119.19 points higher but reversed course to close down by 132.37 points, ending at 82,256.60, a marginal decline of 0.02%. The benchmark index remains 4.74% below its 52-week high of 86,159.02. Notably, the Sensex is trading below its 50-day moving average, although the 50-day average itself is positioned above the 200-day moving average, indicating a mixed technical outlook for the broader market.

In comparison, Shilpa Medicare Ltd’s one-day performance of 10.00% significantly outpaced the Sensex’s flat movement. Over the past week, the stock has gained 19.74%, while the Sensex rose by 0.88%. However, over longer periods, the stock’s returns have been varied: a 0.89% gain over one month versus a 2.86% decline in the Sensex, a 9.95% decline over three months compared to a 2.54% drop in the benchmark, and an 8.26% decline over one year against the Sensex’s 7.16% gain.

Mojo Score and Rating Update

Shilpa Medicare Ltd currently holds a Mojo Score of 29.0, categorised as a Strong Sell grade. This represents a downgrade from its previous Sell rating, effective from 19 Nov 2025. The company’s Market Cap Grade stands at 3, reflecting its relative market capitalisation within the Pharmaceuticals & Biotechnology sector. Despite the recent intraday strength, these ratings indicate a cautious stance based on comprehensive financial and market metrics.

Volatility and Price Movement Analysis

The stock’s heightened intraday volatility of 17.93% underscores the active trading environment surrounding Shilpa Medicare Ltd. Such volatility often reflects rapid shifts in investor sentiment and can lead to significant price fluctuations within a single session. The stock’s ability to maintain gains above short-term moving averages suggests resilience amid this volatility, although the gap below longer-term averages points to ongoing price consolidation.

Longer-Term Performance Overview

Examining Shilpa Medicare Ltd’s performance over extended periods reveals a mixed trajectory. The stock has delivered a 155.97% return over three years, substantially outperforming the Sensex’s 38.25% gain in the same timeframe. However, over five and ten years, the stock’s returns of 49.45% and 50.60% respectively lag behind the Sensex’s 77.71% and 230.74% gains. Year-to-date, the stock has declined marginally by 0.68%, while the Sensex has fallen by 3.48%, indicating relative stability in the current calendar year.

Summary of Trading Action

In summary, Shilpa Medicare Ltd’s trading session on 1 Feb 2026 was marked by a strong intraday rally, with the stock reaching Rs 313.5 and closing with a 7.95% gain. This performance was supported by elevated volatility and a positive short-term technical setup. Despite the broader market’s subdued movement, the stock outperformed both its sector and the Sensex benchmark. The recent upgrade in Mojo Grade to Strong Sell from Sell reflects ongoing caution in the stock’s fundamental outlook, even as short-term price action shows strength.

Investors and market participants will note the divergence between the stock’s short-term momentum and its longer-term technical and rating indicators, highlighting the complexity of its current market position.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →